{
    "clinical_study": {
        "@rank": "148015", 
        "arm_group": [
            {
                "arm_group_label": "Routine", 
                "arm_group_type": "Active Comparator", 
                "description": "IV Hydration at 125 cc hour"
            }, 
            {
                "arm_group_label": "Intervention", 
                "arm_group_type": "Experimental", 
                "description": "IV Hydration at 250 cc hour"
            }
        ], 
        "brief_summary": {
            "textblock": "The hypothesis of the present study is the hydration of nulliparous women with 250ml/hour\n      vs. 125ml/hrs would decrease the rate of primary cesarean section."
        }, 
        "brief_title": "Hydration and Rate of Cesarean Delivery Among Nulliparous", 
        "completion_date": {
            "#text": "July 2018", 
            "@type": "Anticipated"
        }, 
        "condition": "Pregnancy", 
        "detailed_description": {
            "textblock": "For this non-blinded randomized clinical trial (RCT) we will recruit approximately 670 women\n      which meet the inclusion criteria across three sites (Eastern Virginia Medical School\n      (EVMS), University of Arkansas for Medical Sciences (UAMS) and Obstetrix Medical Group, in\n      California). When the patient is being scheduled for induction by her physician or when she\n      presents to L&D for induction or in labor, but her cervical dilation on admission is less\n      than 4 cm, the participants will be consented, and then randomized into a study intervention\n      group. Both groups will receive maintenance IV hydration with Lactated Ringer's (LR)\n      solution: Group I will receive LR at 125 ml/hr and group II will receive LR at 250ml/hr.\n      Other than the rate of maintenance IV infusion, the two groups will receive routine\n      intrapartum care."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\u2022 Non-anomalous singleton\n\n          -  Nulliparous (no prior delivery after 20 weeks)\n\n          -  Presenting at \u226537 weeks of gestation\n\n          -  Presenting for anticipated induction of labor or spontaneous labor (regular\n             contractions for more than 2 hours), but cervical dilation less than 4 cm\n\n          -  Rupture of membranes\n\n          -  Expected to deliver at one of the participating hospitals\n\n        Exclusion Criteria:\u2022 Not in the inclusion criteria\n\n          -  Autoimmune disorders (antiphospholipid antibody, lupus, rheumatoid arthritis,\n             scleroderma)\n\n          -  Diabetes mellitus\u2014gestational or pre-gestational\n\n          -  Enrollment in another randomized clinical trial\n\n          -  Hematologic disorders (coagulation defects, sickle cell disease, thrombocytopenia,\n             thrombophilia)\n\n          -  Hypertension (chronic or pregnancy induced) before randomization\n\n          -  HIV (human immunodeficiency virus)\n\n          -  Placenta previa / 3rd trimester bleeding\n\n          -  Renal insufficiency (serum creatinine > 1.5 mg/dL)\n\n          -  Restrictive lung disease\n\n          -  Seizure disorder on medication\n\n          -  Thyroid disease on medication\n\n          -  Any contraindications to vaginal delivery (breech, active herpes, schedule cesarean,\n             abnormal fetal heart tracing)"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "55 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "670", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 6, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01944787", 
            "org_study_id": "12-05-SP-50"
        }, 
        "intervention": [
            {
                "arm_group_label": "Routine", 
                "description": "IV Hydration at 125 cc hour", 
                "intervention_name": "Routine", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "Intervention", 
                "description": "IV Hydration at 250 cc hour", 
                "intervention_name": "IV Hydration at 250cc hour", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 17, 2013", 
        "location": {
            "contact": {
                "email": "andrew_combs@obstsetrix.com", 
                "last_name": "C A Combs, MD PhD", 
                "phone": "408-371-7111", 
                "phone_ext": "130"
            }, 
            "contact_backup": {
                "email": "kimberly_mallory@pediatrix.com", 
                "last_name": "kimberly m mallory, RNC", 
                "phone": "4087613565"
            }, 
            "facility": {
                "address": {
                    "city": "Campbell", 
                    "country": "United States", 
                    "state": "California", 
                    "zip": "95008"
                }, 
                "name": "C A Combs MD PhD"
            }, 
            "investigator": {
                "last_name": "C A Combs, MD PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intrapartum Hydration and Rate of Cesarean Delivery Among Nulliparous at > 37 Weeks: A Multicenter Randomized", 
        "other_outcome": [
            {
                "measure": "The rate of tachysystole (uterine contractions more than 5 in 10 minutes, n/%)", 
                "safety_issue": "No", 
                "time_frame": "5 Years"
            }, 
            {
                "measure": "The rate of non-reassuring fetal-heart reassuring tracing treated with terbutaline or other tocolytic agent (n/%)", 
                "safety_issue": "No", 
                "time_frame": "5 Years"
            }, 
            {
                "measure": "The indication for cesarean delivery (n/%) versus The indication for operative vaginal delivery (n/%)", 
                "safety_issue": "Yes", 
                "time_frame": "5 Years"
            }, 
            {
                "description": "chorioamnionitis\nendometritis\nwound infection\nwound disruption\nblood transfusion", 
                "measure": "Maternal complications (as diagnosed by managing clinician, (n/%) for all):", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "description": "Apgar score at 1 and 5 min\nBirth weight (grams)\nGender (male/female/unknown)\nUmbilical arterial pH if available (pH units)\nUmbilical arterial base excess if available (mmol/L)\nAdmission to neonatal intensive care unit (n/%)\nIndication for NICU admission (n/%)\nDuration of hospitalization (days)\nMorbidity defined as one or more of the following as diagnosed by managing physician:  Respiratory Distress Syndrome (RDS), Intraventricular Hemorrhage (IVH) grade III/ IV, Necrotizing Enterocolitis (NEC), proven sepsis,seizures (n/%)\nMortality (n/%)", 
                "measure": "Neonatal outcomes (as diagnosed by managing clinician, (n/%) for all):", 
                "safety_issue": "No", 
                "time_frame": "5 Years"
            }, 
            {
                "measure": "Time of Randomization to complete dilation/ minutes", 
                "safety_issue": "No", 
                "time_frame": "5 Years"
            }, 
            {
                "measure": "Time from complete cervical dilation to delivery of newborn/ minutes", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Time from delivery of newborn to delivery of placenta/ minutes", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }
        ], 
        "overall_contact": {
            "email": "mfmchauhan@gmail.com", 
            "last_name": "Suneet Chauhan, MD", 
            "phone": "757-672-5955"
        }, 
        "overall_official": [
            {
                "last_name": "Suneet P Chauhan, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Obstetrix Medical Group", 
                "last_name": "Andrew Combs, MD PhD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The primary objective of this multi-center RCT is to determine if hydration with 250 ml/hr, when compared to traditional 125 ml/hr, significantly decreases the rate of primary cesarean delivery nulliparous.", 
            "measure": "rate of cesarean section", 
            "safety_issue": "No", 
            "time_frame": "5 Years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01944787"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "The secondary objectives of this randomized trial are to compare the 2 groups regarding:\nTime from randomization to delivery (minutes)", 
            "measure": "labor", 
            "safety_issue": "No", 
            "time_frame": "5 Years"
        }, 
        "source": "Chauhan, Suneet P.,  M.D.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chauhan, Suneet P.,  M.D.", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}